AU4598100A - Treating cancer - Google Patents

Treating cancer

Info

Publication number
AU4598100A
AU4598100A AU45981/00A AU4598100A AU4598100A AU 4598100 A AU4598100 A AU 4598100A AU 45981/00 A AU45981/00 A AU 45981/00A AU 4598100 A AU4598100 A AU 4598100A AU 4598100 A AU4598100 A AU 4598100A
Authority
AU
Australia
Prior art keywords
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45981/00A
Other languages
English (en)
Inventor
Barry Roger Barraclough
Philip Spencer Rudland
Hilmar Meek Warenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911302.9A external-priority patent/GB9911302D0/en
Priority claimed from GB0007254A external-priority patent/GB0007254D0/en
Application filed by University of Liverpool filed Critical University of Liverpool
Publication of AU4598100A publication Critical patent/AU4598100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU45981/00A 1999-05-14 2000-05-15 Treating cancer Abandoned AU4598100A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9911302.9A GB9911302D0 (en) 1999-05-14 1999-05-14 Treating cancer
GB9911302 1999-05-14
GBGB9914971.8A GB9914971D0 (en) 1999-05-14 1999-06-25 Treating cancer
GB9914971 1999-06-25
GB0007254 2000-03-24
GB0007254A GB0007254D0 (en) 1999-05-14 2000-03-24 Treating cancer
PCT/GB2000/001866 WO2000070352A1 (fr) 1999-05-14 2000-05-15 Traitement du cancer

Publications (1)

Publication Number Publication Date
AU4598100A true AU4598100A (en) 2000-12-05

Family

ID=27255622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45981/00A Abandoned AU4598100A (en) 1999-05-14 2000-05-15 Treating cancer

Country Status (2)

Country Link
AU (1) AU4598100A (fr)
WO (1) WO2000070352A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010132958A1 (fr) * 2009-05-22 2010-11-25 Garvan Institute Of Medical Research Procédés pour prédire la réactivité à un traitement
GB201219487D0 (en) 2012-10-30 2012-12-12 Cancer Rec Tech Ltd Anti-S100A4 antibody molecules and their uses

Also Published As

Publication number Publication date
WO2000070352A1 (fr) 2000-11-23

Similar Documents

Publication Publication Date Title
AU2020501A (en) Chemotherapy treatment
AU6908500A (en) Treatment for narcolepsy
AU5089400A (en) Arthritis treatment
EP1176964B8 (fr) Utilisation du compose et743 pour le traitement du cancer
HUP0104857A3 (en) New cancer treatments
AU1772399A (en) Well treatment
GB9805877D0 (en) Cancer
AU2002308642A1 (en) Methods for treating cancer
AU5547000A (en) Novel treatment
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU4556800A (en) Novel treatment
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU2001257325A1 (en) Cancer treatment
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU6006800A (en) Treating cells
AU4598100A (en) Treating cancer
AU1669600A (en) New cancer treatments
GB9804361D0 (en) Cancer treatment
AU2001289127A1 (en) Tumor treatment
AU2616201A (en) Cancer treatment method
AU2001257168A1 (en) Cancer treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase